ORAMED PHARMACEUTICALS INC. overview

Oramed Letter to Shareholders PR Newswire NEW YORK, Feb. 20, 2024 Initiating Phase 3 oral insulin trial in the United States under a new protocol JV with Chinese Partner, HTIT Scilex Senior Secured Note PeriTech Asset Purchase & Strategic Out-licensing NEW YORK , Feb. 20, 2024 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today issued a Letter to...

Thinking about buying stock in MicroAlgo, Oramed Pharmaceuticals, Limbach Holdings, Niu Technologies, or Applied Molecular Transport? PR Newswire NEW YORK, Sept. 22, 2023 NEW YORK , Sept. 22, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MLGO, ORMP, LMB, NIU, and AMTI. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. MLGO:...

Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company PR Newswire NEW YORK, Sept. 21, 2023 18-month loan with interest rate of SOFR plus 8.5% Oramed receives warrants to purchase up to 17 million shares of Scilex common stock The Senior Secured Note with Scilex replaces Oramed's previously announced Stock Purchase Agreement and DIP Term Loan with Sorrento Therapeutics NEW YORK , Sept. 21, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq:...

Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally PR Newswire NEW YORK, Aug. 2, 2023 JV will have global marketing rights to oral drug delivery technology HTIT to invest $60 million , Oramed to invest $10 million into JV HTIT to provide a supply agreement for oral insulin capsule JV to advance registration of oral insulin in the United States and other countries NEW YORK , Aug. 2, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc....

Oramed to Present at the 83rd American Diabetes Association Conference PR Newswire NEW YORK, June 20, 2023 NEW YORK , June 20, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), announced today that it has been selected to present an oral abstract presentation at the American Diabetes Association's 83rd Scientific Sessions, taking place between June 23-26, 2023 in San Diego, California . The presentation will include an overview of data from Oramed's...

Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit PR Newswire NEW YORK, May 18, 2023 NEW YORK , May 18, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ), announced today that Chief Scientific Officer Dr. Miriam Kidron will deliver an in-person presentation at the Novel Therapies for Type 2 Diabetes & Obesity Summit in Boston, MA , on May 31, 2023 . The presentation will include an overview of Oramed's oral delivery technology...

Oramed Announces that its Chinese Partner, HTIT, has Successfully Completed a Phase 3 Oral Insulin Clinical Trial and Submitted a Marketing Authorization Application in China PR Newswire NEW YORK, May 15, 2023 Oramed has completed an analysis of its U.S.-based Phase 3 oral insulin trial with significant lowering of A1C levels seen in patient subgroups NEW YORK , May 15, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) ( www.oramed.com ) announced today that Hefei...

Thinking about buying stock in Zillow, Li Auto, Endeavour Silver, Protalix Biotherapeutics, or Oramed Pharmaceuticals? PR Newswire NEW YORK, May 4, 2023 NEW YORK , May 4, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for Z, LI, EXK, PLX, and ORMP. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. Z:...